Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]

Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]

The BioIndustry Association (BIA) has released a new explainer highlighting [...]